Blasticidin

 
Cell line Species Tissue Culture medium Cencentration
293 human kidney; fetal Minimal essential medium 2.50 (μg/ml)
A-431 human epidermis; epidermoid carcinoma Dulbecco's modified Eagle's medium 20 (μg/ml)
MCF 10A human mammary gland; fibrocystic disease endothelial cell growth medium (EGM) 5 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 2 (μg/ml)
NIH/3T3 mouse embryo Dulbecco's modified Eagle's medium 2 (μg/ml)
NIH/3T3 mouse embryo Dulbecco's modified Eagle's medium 2 (μg/ml)
WI-38 VA-13 subline 2RA human lung Dulbecco's modified Eagle's medium 5 (μg/ml)
3T3-L1 mouse embryo Dulbecco's modified Eagle's medium 5 (μg/ml)
CHO hamster, Chinese ovary Dulbecco's modified Eagle's medium 10 (μg/ml)
CHO hamster, Chinese ovary Ham’s F-12 nutrient mixture 10 (μg/ml)
Jurkat, Clone E6-1 human T lymphocyte; acute T cell leukemia RPMI 1640 Medium 5 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 5 (μg/ml)
H9 human RPMI 1640 Medium 5 (μg/ml)
B16-F1 mouse skin; melanoma Dulbecco's modified Eagle's medium 6.25 (μg/ml)
NIH/3T3 mouse embryo Dulbecco's modified Eagle's medium 25 (μg/ml)
NIH/3T3 mouse embryo 50 (μg/ml)
COS-1 monkey, African green kidney Dulbecco's modified Eagle's medium 5 (μg/ml)
HeLa human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 10 (μg/ml)
HeLa S3 human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 10 (μg/ml)
HeLa S3 human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 10 (μg/ml)
BINE4.8 RPMI 1640 Medium 10 (μg/ml)
A-431 human epidermis; epidermoid carcinoma Dulbecco's modified Eagle's medium 0.6 (μg/ml)
A-431 human epidermis; epidermoid carcinoma α-modified minimal essential medium 5 (μg/ml)
Ba/F3 RPMI 1640 Medium 5 (μg/ml)
SW 1990 human spleen (metastasis); adenocarcinoma (pancreas primary) RPMI 1640 Medium 50 (μg/ml)